3 results about "Lost appetite" patented technology

The application provides a patchouli composition for removing dampness, invigorating the spleen, refreshing the brain and calming the nerves and a preparation method and application thereof, and belongs to the technical field of functional food. The composition comprises the following raw materials: patchouli, 10-20 parts; tuckahoe, 8-18 parts; bergamot, 5-15 parts; dried tangerine or orange peel, 3-10 parts; and fried licorice, 2-6 parts. The application takes five kinds of food-medicine homologous materials, namely, patchouli, tuckahoe, bergamot, dried tangerine or orange peel and fried licorice, as core effective components, realizes the synergistic effects of removing dampness and turbidity, invigorating the spleen and stomach, soothing the liver and regulating qi, refreshing the brain and calming the nerves through scientific proportioning, and can be prepared into various edible dosage forms such as granules, oral liquid and ointment, and is especially suitable for modern sub-healthy people with heavy dampness, weak spleen and stomach, emotional irritability, dizziness, poor appetite and heavy limbs, is mild and safe, has no side effects, is suitable for long-term conditioning, and belongs to the technical field of functional conditioning food with food-medicine homology.

The present invention relates to a pharmaceutical composition for preventing, ameliorating, or treating anorexia and weight loss, comprising a Bupleuri Radix extract. Specifically, the present invention provides a pharmaceutical composition having effects in preventing, ameliorating, or treating anorexia and weight loss, wherein a Bupleuri Radix extract increases ghrilin, which is a hormone that stimulates appetite, and decreases TPH1(I), which is a serotonin synthase. In addition, a health functional food for preventing or ameliorating anorexia and weight loss, comprising a Bupleuri Radix extract, can be developed, and the extract can be effectively used for the treatment and the development of therapeutic agents for anorexia induced by chemotherapy in the future.

This invention discloses a tumor adjuvant nutritional preparation based on *Pterocarya stenoptera* oil, its preparation method, and its application. The active ingredients of this preparation are composed of *Pterocarya stenoptera* oil, ω-3 fatty acids, and arginine in a mass ratio of (1-3):(1-2):(1-2), preferably 2:1:1. The preparation method includes mixing the above components evenly, followed by high-pressure homogenization and aseptic emulsification to produce an oral liquid, enteral nutrition emulsion, or powder. This preparation can effectively improve chemotherapy-induced bone marrow suppression, significantly increase white blood cell, red blood cell, and hemoglobin levels, enhance serum superoxide dismutase activity, reduce oxidative stress damage, and significantly alleviate gastrointestinal adverse reactions such as nausea, vomiting, and loss of appetite in cancer patients undergoing radiotherapy and chemotherapy, improving patients' nutritional status and quality of life, and exhibiting good safety.